Pathways in the Pathophysiology of Coronavirus 19 Lung Disease Accessible to Prevention and Treatment
Eisenhut M, Shin J. Pathways in the Pathophysiology of Coronavirus 19 Lung Disease Accessible to Prevention and Treatment. Frontiers In Physiology 2020, 11: 872. PMID: 32922301, PMCID: PMC7457053, DOI: 10.3389/fphys.2020.00872.Peer-Reviewed Original ResearchCystic fibrosis transmembrane conductance regulatorAcute respiratory distress syndromeTNF-alpha levelsTNF-alphaLung diseaseRandomized Controlled TrialsEpithelial sodiumReduction of TNF-alpha productionCystic fibrosis transmembrane conductance regulator activityChloride transportAnti-TNF-alpha treatmentAlveolar spaceTumor necrosis factor-alphaHuman beta-defensin-2Associated with improved outcomesVitamin D prophylaxisRespiratory distress syndromeTNF-alpha concentrationsTransmembrane conductance regulatorTNF-alpha releasePhosphodiesterase-5 inhibitorsNecrosis factor-alphaTNF-alpha productionImpairment of sodiumBeta-defensin-2
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply